Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 Apr 15;7(4):639. doi: 10.1001/jamaoncol.2021.0685

Errors in Author Names and Affiliations

PMCID: PMC8050739  PMID: 33856417

In the Original Investigation entitled “Comparison of Multiparametric Magnetic Resonance Imaging–Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial,”1 there are errors in multiple author names and affiliations. “Ashley Machado” should be “Ashley Mercado,” “Sylvia Chang” should be “Sylvia D. Chang,” “Carolyn Moore” should be “Caroline Moore,” and “Veeru Kasivisanathan” should be “Veeru Kasivisvanathan.” The affiliation listed for Zahra Kassam was “Jewish General Hospital, McGill University, Montreal, Québec, Canada,” but should be “London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada,” and the affiliation listed for Sylvia D. Chang was “London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada,” but should be “Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.” Additionally, the description of TRUS MRI fusion software in the Methods included “(Artemis or Koelis)” but should instead include “(Artemis, UroNav, or Koelis).” This article was corrected online.

Reference

  • 1.Klotz LH, Haider MS, Chin JL, et al. Comparison of multiparametric magnetic resonance imaging–targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial. JAMA Oncol. Published online February 4, 2021. doi: 10.1001/jamadermatol.2020.7589 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Oncology are provided here courtesy of American Medical Association

RESOURCES